Pune: Serum Institute of India (SII) has sought approval from Drugs Controller General of India (DCGI) for Covishield to be administered in the form of booster dose.
In an application to drugs regulator DCGI, Prakash Kumar Singh, Director, Government and Regulatory Affairs at Serum Institute, has cited adequate vaccine stock in India and a necessity for a booster shot especially after the emergence of new coronavirus variants, PTI reported quoting sources.
SII further mentioned that UK’s Medicines and Healthcare products Regulatory Agency has already approved booster dose of Oxford-AstraZeneca’s ChAdOx1 nCoV-19 vaccine. Since Serum Institute is manufacturing the same vaccine in a different brand name (Covishield), it’s only logical that India should embrace it.
Also Read: Omicron-Specific Booster Shot Possible, Says Adar Poonawala
Unlike countries like the US, UK, Germany, India has not decided on introducing a booster shot for its citizens. But a decision on the matter may be announced soon.
Also Read: COVID Vaccine: Policy On Booster & Additional Dose To Be Made Public In 2 Weeks
Puri: The Ratha Yatra Coordination Committee held its first meeting to discuss the preparations for…
New Delhi: Filmmaker Rohit Shetty, on Friday, presented Deepika Padukone as Lady Singham. Shetty posted…
Cuttack: Junior Revenue Assistant at the Collectorate in Odisha's Angul Pankajini Biswal was on Saturday…
New Delhi: Popular fashion and beauty influencer Surbhi Jain recently passed away after a prolonged…
Bhubaneswar: Odisha Police on Saturday began testing airconditioned (AC) helmets to protect traffic constables from…
Bhubaneswar: The blistering heatwave is likely to sear Odisha till tomorrow with the India Meteorological…
Sambalpur: Odisha’s Sambalpur University has once again suspended Assistant Professor in Political Science and Public…
Mumbai: It was announced four months ago that ‘Animal’, one of the top grossers among…